Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	327	150	206	196	124	408
Market Cap Growth	116.68%	-27.32%	5.07%	57.73%	-69.53%	19.67%
Enterprise Value	273	139	233	233	154	420
Last Close Price	6.48	3.05	4.33	4.23	3.04	10.26
PE Ratio	8.71	4.95	9.54	98021.07	-	-
Forward PE	14.81	11.62	10.57	33.92	-	-
PS Ratio	1.52	0.65	0.87	0.86	0.49	1.81
PB Ratio	2.83	1.63	3.85	9.07	-50.81	-68.55
P/TBV Ratio	4.57	3.65	-	-	-	-
P/FCF Ratio	7.62	3.85	7.67	-	6.02	561.16
P/OCF Ratio	7.60	3.85	7.63	-	6.02	527.77
EV/Sales Ratio	1.29	0.61	0.99	1.02	0.61	1.86
EV/EBITDA Ratio	6.11	3.28	5.21	5.74	12.22	-
EV/EBIT Ratio	8.14	4.50	7.01	7.58	119.32	-
EV/FCF Ratio	6.37	3.59	8.68	-	7.45	577.31
Debt / Equity Ratio	0.36	0.80	2.09	5.29	-47.69	-20.32
Debt / EBITDA Ratio	0.86	1.61	2.27	2.54	6.78	-
Debt / FCF Ratio	0.96	1.91	4.15	-	5.65	166.37
Asset Turnover	1.00	1.04	1.04	1.02	1.08	0.94
Inventory Turnover	8.06	8.15	10.80	9.47	12.06	11.89
Quick Ratio	1.55	1.38	1.45	1.59	1.05	1.04
Current Ratio	1.74	1.54	1.57	1.73	1.28	1.28
Return on Equity (ROE)	39.68%	41.60%	57.54%	0.02%	-	-1042.30%
Return on Assets (ROA)	9.90%	8.72%	9.19%	8.56%	0.34%	-7.93%
Return on Invested Capital (ROIC)	56.00%	46.14%	51.17%	0.31%	4.80%	-127.57%
Return on Capital Employed (ROCE)	27.90%	26.40%	25.40%	21.20%	1.10%	-23.40%
Earnings Yield	11.32%	20.22%	10.48%	0.00%	-23.43%	-14.71%
FCF Yield	13.13%	25.96%	13.04%	-8.07%	16.61%	0.18%
Buyback Yield / Dilution	-2.69%	-3.26%	-5.83%	-10.56%	-2.69%	-2.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q